Jay D. Kranzler

Chief Executive Officer, CYPRESS BIOSCIENCE INC.

Companies

AVENUE THERAPEUTICS, INC.Board member Sep 11, 2017 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

AVENUE THERAPEUTICS, INC. ATXI559 shares²$240 at $0.43Nov 5, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 5, 2024Sold 61 shares at $2.24 of AVENUE THERAPEUTICS, INC.²
Sep 30, 2024Bought 497 shares at $2.50 of AVENUE THERAPEUTICS, INC.³
Sep 27, 2024Bought 3 shares at $2.40 of AVENUE THERAPEUTICS, INC.³
Dec 17, 2021Granted 20,000 shares of AVENUE THERAPEUTICS, INC.⁴
Dec 17, 2021Granted 49,020 shares of AVENUE THERAPEUTICS, INC.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAVENUE THERAPEUTICS, INC., Board member
2
SEC EDGARAVENUE THERAPEUTICS, INC. shares after the filing of Nov 5, 2024
3
SEC EDGARForm 4 filed Oct 1, 2024
4
SEC EDGARForm 4 filed Dec 21, 2021